Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective study

BACKGROUND: Gemcitabine with platinum is one of the most important first-line treatments for metastatic urothelial cancer (mUC). However, continuation of platinum agents results in cumulative toxicities, such as nephrotoxicity, ototoxicity, and neurotoxicity, which lead to discontinuation of chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyunho, Lee, Seung-Hwan, Kim, Dong Hwan, Lee, Ji Youl, Hong, Sung-Hoo, Ha, U-Syn, Kim, In-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658126/
https://www.ncbi.nlm.nih.gov/pubmed/33209674
http://dx.doi.org/10.21037/tau-20-772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658126/
https://www.ncbi.nlm.nih.gov/pubmed/33209674
http://dx.doi.org/10.21037/tau-20-772

Ejemplares similares